The ratio of total AKT to pAKTSer473 was approximately 1:1 in both control-treated lung cancer cell lines (Figure 5B,E), but in siRNA treated cells we found this ratio shifted towards 1:2 and 1:3, respectively. The gene discussed is AKT1; the disease is lung carcinoma.